These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Remestemcel-L, the first cellular therapy product for the treatment of graft-versus-host disease. Daly A Drugs Today (Barc); 2012 Dec; 48(12):773-83. PubMed ID: 23243634 [TBL] [Abstract][Full Text] [Related]
9. Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experience. Conklin LS; Hanley PJ; Galipeau J; Barrett J; Bollard CM Cytotherapy; 2017 Jun; 19(6):655-667. PubMed ID: 28433516 [TBL] [Abstract][Full Text] [Related]
10. Encapsulated mesenchymal stem cells for in vivo immunomodulation. Zanotti L; Sarukhan A; Dander E; Castor M; Cibella J; Soldani C; Trovato AE; Ploia C; Luca G; Calvitti M; Mancuso F; Arato I; Golemac M; Jonjic N; Biondi A; Calafiore R; Locati M; D'Amico G; Viola A Leukemia; 2013 Feb; 27(2):500-3. PubMed ID: 22878604 [No Abstract] [Full Text] [Related]
11. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease. Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells. Dazzi F; Marelli-Berg FM Eur J Immunol; 2008 Jun; 38(6):1479-82. PubMed ID: 18493977 [TBL] [Abstract][Full Text] [Related]
13. Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients. Introna M; Lucchini G; Dander E; Galimberti S; Rovelli A; Balduzzi A; Longoni D; Pavan F; Masciocchi F; Algarotti A; Micò C; Grassi A; Deola S; Cavattoni I; Gaipa G; Belotti D; Perseghin P; Parma M; Pogliani E; Golay J; Pedrini O; Capelli C; Cortelazzo S; D'Amico G; Biondi A; Rambaldi A; Biagi E Biol Blood Marrow Transplant; 2014 Mar; 20(3):375-81. PubMed ID: 24321746 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic effects of human umbilical cord mesenchymal stem cell transplantation on acute graft versus host disease]. Zheng Y; Wang Y; Zhai Z; Zhai Q; Hu SY Zhongguo Dang Dai Er Ke Za Zhi; 2015 Aug; 17(8):869-72. PubMed ID: 26287355 [No Abstract] [Full Text] [Related]
15. Mesenchymal stem cells and organ transplantation: current status and promising future. Bolaños-Meade J; Vogelsang GB Transplantation; 2006 May; 81(10):1388-9. PubMed ID: 16732174 [No Abstract] [Full Text] [Related]
16. [Novel strategy for GVHD treatment: possible use of mesenchymal stem cells and interleukin-21]. Ozaki K Rinsho Ketsueki; 2012 May; 53(5):483-6. PubMed ID: 22728548 [No Abstract] [Full Text] [Related]
18. Experimental therapy of graft-versus-host disease by mesenchymal stromal cells grown on oxide nanocoatings. Goltsev AN; Rassokha IV; Dubrava TG; Ostankova LV; Ostankov MV; Safonov VI; Zykova AV Fiziol Zh (1994); 2016; 62(5):3-11. PubMed ID: 30204336 [TBL] [Abstract][Full Text] [Related]
19. Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease. Ball LM; Bernardo ME; Roelofs H; van Tol MJ; Contoli B; Zwaginga JJ; Avanzini MA; Conforti A; Bertaina A; Giorgiani G; Jol-van der Zijde CM; Zecca M; Le Blanc K; Frassoni F; Egeler RM; Fibbe WE; Lankester AC; Locatelli F Br J Haematol; 2013 Nov; 163(4):501-9. PubMed ID: 23992039 [TBL] [Abstract][Full Text] [Related]
20. [Research progress on immunologic mechanisms of mesenchymal stem cells for treatment of graft-versus-host disease]. Wang RP; Chen H; Guo YQ; Wu RN; Zhang B Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):550-3. PubMed ID: 21518528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]